TARPLIN, DOWNS & YOUNG, LLC

Lobbying for ASTRAZENECA

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Oct 16, 2025

Lobbying activity 3

Budget/Appropriations

federal budget issues

Medicare/Medicaid

Medicare and Medicaid drug and coverage issues, orphan drugs

Health Issues

IRA, drug pricing in federal programs, orphan drug issues, oncology, transparency

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.